The effects of milrinone and dobutamine upon BNP levels in patients with NYHA-class IV decompensated heart failure

被引:0
|
作者
Pontes-Arruda, A [1 ]
机构
[1] Fernandes Tavora Hosp, Dept Intens Care, Fortaleza, Ceara, Brazil
关键词
D O I
10.1097/00003246-200512002-00199
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
引用
收藏
页码:A55 / A55
页数:1
相关论文
共 50 条
  • [41] The effects of nesiritide on serum levels of B-type natriuretic peptide (BNP) in patients admitted for decompensated congestive heart failure
    Maisel, AS
    Cremo, R
    Gardetto, N
    Jaynes, C
    Chiu, A
    [J]. CIRCULATION, 2002, 106 (19) : 565 - 565
  • [42] Association of Repetitive Dosing of Levosimendan with Reduction of NYHA Class and NT-proBNP Levels in Decompensated Heart Failure: A Retrospective Cohort Study
    Wechsler, Maximilian
    Schwinger, Robert H. G.
    [J]. DRUGS-REAL WORLD OUTCOMES, 2022, 9 (03) : 529 - 537
  • [43] Difference plasma nitric oxide level between patients with heart failure NYHA II and NYHA IV
    Pasah, R. R.
    [J]. EUROPEAN JOURNAL OF HEART FAILURE, 2014, 16 : 16 - 16
  • [44] THE DIFFERENTIAL-EFFECTS OF MILRINONE AND DOBUTAMINE ON REGIONAL CIRCULATIONS IN CONGESTIVE-HEART-FAILURE
    THOMAS, A
    IMAI, N
    KAWASHIMA, S
    STONE, CK
    HOOD, WB
    LIANG, C
    [J]. FEDERATION PROCEEDINGS, 1986, 45 (04) : 1050 - 1050
  • [45] Association of Repetitive Dosing of Levosimendan with Reduction of NYHA Class and NT-proBNP Levels in Decompensated Heart Failure: A Retrospective Cohort Study
    Maximilian Wechsler
    Robert H. G. Schwinger
    [J]. Drugs - Real World Outcomes, 2022, 9 : 529 - 537
  • [46] CRT-D therapy in heart failure: How much do NYHA class IV patients benefit?
    Lehmann, MH
    Aaronson, KD
    [J]. JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY, 2006, 17 (05) : 491 - 494
  • [47] Respiratory muscle trainings reduce frequency of pneumonia in patients with NYHA class III-IV heart failure
    Kolesnikova, E. A.
    Arutyunov, G. P.
    Rylova, A. K.
    Rylova, N. V.
    Lobzeva, V. I.
    [J]. EUROPEAN JOURNAL OF HEART FAILURE, 2013, 12 : S277 - S278
  • [48] Efficiency and safety of physical rehabilitation in patients with chronic heart failure III-IV class NYHA candidates for heart transplantation
    Bortsova, M. A.
    Sitnikova, M. U.
    Demchenko, E. A.
    Lelyavina, T. A.
    Babich, O. A.
    Galenko, V. L.
    Fedotov, P. A.
    [J]. EUROPEAN JOURNAL OF HEART FAILURE, 2018, 20 : 86 - 86
  • [49] The Ca2+-sensitizer levosimendan improves oxidative damage, BNP and pro-inflammatory cytokine levels in patients with advanced decompensated heart failure in comparison to dobutamine
    Avgeropoulou, C
    Andreadou, I
    Markantonis-Kyroudis, S
    Demopoulou, M
    Missovoulos, P
    Androulakis, A
    Kallikazaros, I
    [J]. EUROPEAN JOURNAL OF HEART FAILURE, 2005, 7 (05) : 882 - 887
  • [50] MILRINONE, DOBUTAMINE, AND NITROPRUSSIDE - COMPARATIVE EFFECTS ON HEMODYNAMICS AND MYOCARDIAL ENERGETICS IN PATIENTS WITH SEVERE CONGESTIVE-HEART-FAILURE
    MONRAD, ES
    BAIM, DS
    SMITH, HS
    [J]. CIRCULATION, 1986, 73 (03) : 168 - 174